-
摘要: 肿瘤的发生发展深受细胞周围环境的影响。肿瘤细胞与其微环境之间的相互作用已被认为是癌症发展的关键决定因素之一，并且正在得到广泛研究。微生物组可以调节人体的免疫系统和抗肿瘤特性，从而影响膀胱癌的进展和肿瘤发生。因此，微生物组可用作生物标志物以及用于膀胱癌不同阶段的治疗。Abstract: The occurrence and development of tumors are deeply affected by the environment surrounding cells. The interaction between tumor cells and their microenvironment has been recognized as one of the key determinants of cancer development and is being extensively studied. The microbiome can modulate the body's immune system and anti-tumor properties, thereby influencing bladder cancer progression and tumorigenesis. Therefore, the microbiome can be used as a biomarker as well as in the treatment of different stages of bladder cancer.
-
Key words:
- microbiomes /
- bladder cancer
-
-
[1] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. doi: 10.3322/caac.21660
[2] Ma WC, Zhang WT, Shen LL, et al. Can smoking cause differences in urine microbiome in male patients with bladder cancer?A retrospective study[J]. Front Oncol, 2021, 11: 677605. doi: 10.3389/fonc.2021.677605
[3] Roy S, Trinchieri G. Microbiota: a key orchestrator of cancer therapy[J]. Nat Rev Cancer, 2017, 17(5): 271-285. doi: 10.1038/nrc.2017.13
[4] Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system[J]. Nat Rev Immunol, 2017, 17(4): 219-232. doi: 10.1038/nri.2017.7
[5] Coley WB. The Treatment of Inoperable Sarcoma by Bacterial Toxins(the Mixed Toxins of the Streptococcus erysipelas and the Bacillus prodigiosus)[J]. Proc R Soc Med, 1910, 3(Surg Sect): 1-48.
[6] Poore GD, Kopylova E, Zhu QY, et al. Microbiome analyses of blood and tissues suggest cancer diagnostic approach[J]. Nature, 2020, 579(7800): 567-574. doi: 10.1038/s41586-020-2095-1
[7] Sepich-Poore GD, Zitvogel L, Straussman R, et al. The microbiome and human cancer[J]. Science, 2021, 371(6536): eabc4552. doi: 10.1126/science.abc4552
[8] Wu P, Zhang GH, Zhao J, et al. Profiling the urinary microbiota in male patients with bladder cancer in China[J]. Front Cell Infect Microbiol, 2018, 8: 167. doi: 10.3389/fcimb.2018.00167
[9] Oresta B, Braga D, Lazzeri M, et al. The microbiome of catheter collected urine in males with bladder cancer according to disease stage[J]. J Urol, 2021, 205(1): 86-93. doi: 10.1097/JU.0000000000001336
[10] Chipollini J, Wright JR, Nwanosike H, et al. Characterization of urinary microbiome in patients with bladder cancer: Results from a single-institution, feasibility study[J]. Urol Oncol, 2020, 38(7): 615-621. doi: 10.1016/j.urolonc.2020.04.014
[11] Hrbáĉek J, Tláskal V, Ĉermák P, et al. Bladder cancer is associated with decreased urinary microbiota diversity and alterations in microbial community composition[J]. Urol Oncol, 2023, 41(2): 107. e15-107. e22. doi: 10.1016/j.urolonc.2022.09.018
[12] Mansour B, Monyók Á, Makra N, et al. Bladder cancer-related microbiota: examining differences in urine and tissue samples[J]. Sci Rep, 2020, 10(1): 11042. doi: 10.1038/s41598-020-67443-2
[13] Knorr J, Lone Z, Werneburg G, et al. An exploratory study investigating the impact of the bladder tumor microbiome on Bacillus Calmette Guerin(BCG)response in non-muscle invasive bladder cancer[J]. Urol Oncol, 2024: S1078-S1439(24)00430-7.
[14] Hussein AA, Elsayed AS, Durrani M, et al. Investigating the association between the urinary microbiome and bladder cancer: an exploratory study[J]. Urol Oncol, 2021, 39(6): 370. e9-370. e19. doi: 10.1016/j.urolonc.2020.12.011
[15] Sun JX, Xia QD, Zhong XY, et al. The bladder microbiome of NMIBC and MIBC patients revealed by 2bRAD-M[J]. Front Cell Infect Microbiol, 2023, 13: 1182322. doi: 10.3389/fcimb.2023.1182322
[16] Zeng JR, Zhang GH, Chen CX, et al. Alterations in urobiome in patients with bladder cancer and implications for clinical outcome: a single-institution study[J]. Front Cell Infect Microbiol, 2020, 10: 555508. doi: 10.3389/fcimb.2020.555508
[17] Nadler N, Kvich L, Bjarnsholt T, et al. The discovery of bacterial biofilm in patients with muscle invasive bladder cancer[J]. APMIS, 2021, 129(5): 265-270. doi: 10.1111/apm.13097
[18] Mai GQ, Chen LM, Li R, et al. Common core bacterial biomarkers of bladder cancer based on multiple datasets[J]. Biomed Res Int, 2019, 2019: 4824909.
[19] Ahn HK, Kim K, Park J, et al. Urinary microbiome profile in men with genitourinary malignancies[J]. Investig Clin Urol, 2022, 63(5): 569-576. doi: 10.4111/icu.20220124
[20] Bi H, Tian Y, Song C, et al. Urinary microbiota-a potential biomarker and therapeutic target for bladder cancer[J]. J Med Microbiol, 2019, 68(10): 1471-1478. doi: 10.1099/jmm.0.001058
[21] Liu F, Liu AW, Lu X, et al. Dysbiosis signatures of the microbial profile in tissue from bladder cancer[J]. Cancer Med, 2019, 8(16): 6904-6914. doi: 10.1002/cam4.2419
[22] El-Mosalamy H, Salman TM, Ashmawey AM, et al. Role of chronic E. coli infection in the process of bladder cancer-an experimental study[J]. Infect Agent Cancer, 2012, 7(1): 19. doi: 10.1186/1750-9378-7-19
[23] Guo YX, Wang JY, Zhou KC, et al. Cytotoxic necrotizing factor 1 promotes bladder cancer angiogenesis through activating RhoC[J]. FASEB J, 2020, 34(6): 7927-7940. doi: 10.1096/fj.201903266RR
[24] Qiu YF, Gao YB, Chen CX, et al. Deciphering the influence of urinary microbiota on FoxP3+ regulatory T cell infiltration and prognosis in Chinese patients with non-muscle-invasive bladder cancer[J]. Hum Cell, 2022, 35(2): 511-521. doi: 10.1007/s13577-021-00659-0
[25] Bukavina L, Isali I, Ginwala R, et al. Global Meta-analysis of urine microbiome: colonization of polycyclic aromatic hydrocarbon-degrading bacteria among bladder cancer patients[J]. Eur Urol Oncol, 2023, 6(2): 190-203. doi: 10.1016/j.euo.2023.02.004
[26] Pederzoli F, Ferrarese R, Amato V, et al. Sex-specific alterations in the urinary and tissue microbiome in therapy-naïve urothelial bladder cancer patients[J]. Eur Urol Oncol, 2020, 3(6): 784-788. doi: 10.1016/j.euo.2020.04.002
[27] Yin ZF, Liu BH, Feng SJ, et al. A large genetic causal analysis of the gut microbiota and urological cancers: a bidirectional Mendelian randomization study[J]. Nutrients, 2023, 15(18): 4086. doi: 10.3390/nu15184086
[28] Griffin LE, Kohrt SE, Rathore A, et al. Microbial metabolites of flavanols in urine are associated with enhanced anti-proliferative activity in bladder cancer cells in vitro[J]. Nutr Cancer, 2022, 74(1): 194-210. doi: 10.1080/01635581.2020.1869277
[29] Mager LF, Burkhard R, Pett N, et al. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy[J]. Science, 2020, 369(6510): 1481-1489. doi: 10.1126/science.abc3421
[30] Then CK, Paillas S, Wang XD, et al. Association of Bacteroides acidifaciens relative abundance with high-fibre diet-associated radiosensitisation[J]. BMC Biol, 2020, 18(1): 102. doi: 10.1186/s12915-020-00836-x
[31] Moonen PMJ, Bakkers JMJE, Kiemeney LALM, et al. Human papilloma virus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer[J]. Eur Urol, 2007, 52(2): 464-468. doi: 10.1016/j.eururo.2006.11.017
[32] Nakagawa T, Shigehara K, Kato Y, et al. Are bladder washing samples suitable for investigation of HPV infection in urinary bladder?Comparison in HPV prevalence between urine and washing samples[J]. J Med Virol, 2023, 95(1): e28110. doi: 10.1002/jmv.28110
[33] Sun JX, Xu JZ, Liu CQ, et al. The association between human papillomavirus and bladder cancer: Evidence from meta-analysis and two-sample Mendelian randomization[J]. J Med Virol, 2023, 95(1): e28208. doi: 10.1002/jmv.28208
[34] Yao XY, Xu ZZ, Duan C, et al. Role of human papillomavirus and associated viruses in bladder cancer: an updated review[J]. J Med Virol, 2023, 95(9): e29088. doi: 10.1002/jmv.29088
[35] Park EG, Lee DH, Kim WR, et al. Human endogenous retrovirus-H-derived miR-4454 inhibits the expression of DNAJB4 and SASH1 in non-muscle-invasive bladder cancer[J]. Genes, 2023, 14(7): 1410. doi: 10.3390/genes14071410
[36] Santos LL, Santos J, Gouveia MJ, et al. Urogenital schistosomiasis-history, pathogenesis, and bladder cancer[J]. J Clin Med, 2021, 10(2): 205. doi: 10.3390/jcm10020205
[37] Sedighi M, Zahedi Bialvaei A, Hamblin MR, et al. Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities[J]. Cancer Med, 2019, 8(6): 3167-3181. doi: 10.1002/cam4.2148
[38] Osuna-Pérez J, García-Ferreras R, Veiga E. From cellular microbiology to bacteria-based next generations of cancer immunotherapies[J]. Cell Microbiol, 2020, 22(4): e13187.
[39] Wang CY, Lei LJ, Xu Y, et al. Trichostatin C synergistically interacts with DNMT inhibitor to induce antineoplastic effect via inhibition of axl in bladder and lung cancer cells[J]. Pharmaceuticals(Basel), 2024, 17(4): 425. doi: 10.3390/ph17040425
[40] Miyake M, Oda Y, Owari T, et al. Probiotics enhances anti-tumor immune response induced by gemcitabine plus cisplatin chemotherapy for urothelial cancer[J]. Cancer Sci, 2023, 114(3): 1118-1130. doi: 10.1111/cas.15666
[41] de Lima Fragelli BD, Camillo L, de Almeida Rodolpho JM, et al. Antitumor effect of IL-2 and TRAIL proteins expressed by recombinant Salmonella in murine bladder cancer cells[J]. Cell Physiol Biochem, 2021, 55(4): 460-476. doi: 10.33594/000000398
[42] Butler DSC, Cafaro C, Putze J, et al. A bacterial protease depletes c-MYC and increases survival in mouse models of bladder and colon cancer[J]. Nat Biotechnol, 2021, 39(6): 754-764. doi: 10.1038/s41587-020-00805-3
[43] Baruch EN, Youngster I, Ben-Betzalel G, et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients[J]. Science, 2021, 371(6529): 602-609. doi: 10.1126/science.abb5920
[44] Dizman N, Meza L, Bergerot P, et al. Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial[J]. Nat Med, 2022, 28(4): 704-712. doi: 10.1038/s41591-022-01694-6
[45] Pederzoli F, Bandini M, Raggi D, et al. Is there a detrimental effect of antibiotic therapy in patients with muscle-invasive bladder cancer treated with neoadjuvant pembrolizumab?[J]. Eur Urol, 2021, 80(3): 319-322. doi: 10.1016/j.eururo.2021.05.018
-
计量
- 文章访问数: 293
- 施引文献: 0
下载: